Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 86.93M | $ -2.85M | $ 0 | 3.28% |
3/31/2025 | $ 89.87M | $ -2.48M | $ 0 | 2.76% |
12/31/2024 | $ 93.96M | $ -2.48M | $ 0 | 2.64% |
9/30/2024 | $ 95.94M | $ -1.29M | $ 0 | 1.35% |
6/30/2024 | $ 91.32M | $ -2K | $ 0 | 0% |
3/31/2024 | $ 96.7M | $ -2K | $ 0 | 0% |
12/31/2023 | $ 116.29M | $ 2.43M | $ 0 | -2.09% |
9/30/2023 | $ 78.66M | $ 6.6M | $ 0 | -8.39% |
6/30/2023 | $ 128.48M | $ 11.02M | $ 0 | -8.58% |
3/31/2023 | $ 112.88M | $ 11.02M | $ 0 | -9.77% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for ORAMED PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 23.79M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 65.82M ]
(=) Payout Yield [ -36.14% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |